Your phone could help monitor MS: new study tests digital biomarkers
NCT ID NCT05009160
First seen Mar 13, 2026 · Last updated May 23, 2026 · Updated 12 times
Summary
This study tests whether a smartphone app can reliably measure multiple sclerosis (MS) symptoms and predict disease worsening. About 300 adults with MS will use the app for two years to complete challenges and surveys. The goal is to develop digital biomarkers that complement traditional tests like MRI and blood work, offering more frequent and real-world insights into how MS affects daily life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centro Sclerosi Multipla, Ospedale Regionale di Lugano
Lugano, Switzerland, Switzerland
-
Department of Neurology, CHUV Lausanne
Lausanne, Switzerland, Switzerland
-
Klinik für Neurologie, Kantonsspital St. Gallen
Sankt Gallen, Switzerland, Switzerland
-
Klinik für Neurologie, Universitätsspital Zürich
Zurich, Switzerland, Switzerland
-
MS Center, Department of Neurology University Hospital Basel
Basel, Switzerland
-
Neurozentrum, Kantonsspital Aarau
Aarau, Switzerland, Switzerland
Conditions
Explore the condition pages connected to this study.